NYSE · Financial Statements

Labcorp Holdings Inc. (LH) Financial Statements

$328.95 NYSE: LH Market Cap $26.68B

Labcorp Holdings Inc. most recently reported annual revenue of $14.0B, net profit of $877.0M. Revenue was roughly flat over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Labcorp Holdings Inc.: Revenue rose from $9.6B in 2016 to $14.0B in 2025, a change of +44.7% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 13.6% to 10.9%, a shift of -2.7 percentage points; the most recent year shows net profit of $877.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$9.6B$10.4B$11.3B$11.6B$14.0B$13.1B$11.9B$12.2B$13.0B$14.0B
Operating Expenses$8.3B$9.1B$10.0B$10.2B$11.5B$10.1B$10.4B$11.4B$11.9B$12.4B
Operating Profit$1.3B$1.4B$1.3B$1.3B$2.4B$3.0B$1.4B$726.0M$1.1B$1.5B
Operating Margin13.6%13.1%11.7%11.5%17.5%23.2%12.1%6.0%8.3%10.9%
Other Income$-207.0M$-228.0M$-57.0M$-225.0M$-226.0M$-161.0M$-199.0M$-157.0M$-127.0M$-409.0M
Interest$219.0M$235.0M$244.0M$241.0M$207.0M$212.0M$180.0M$200.0M$208.0M$224.0M
Depreciation$491.0M$533.0M$552.0M$771.0M$825.0M$577.0M$537.0M$577.0M$644.0M$681.0M
Profit Before Tax$1.1B$1.1B$1.3B$1.1B$2.2B$2.9B$1.2B$569.0M$960.0M$1.1B
Tax$33.7M$-12.3M$30.3M$25.3M$29.8M$23.9M$18.9M$33.1M$22.1M$20.8M
Net Profit$732.0M$1.3B$884.0M$824.0M$1.6B$2.4B$1.3B$418.0M$746.0M$877.0M
EPS$7.02$12.21$8.61$8.36$15.88$24.38$13.96$4.77$8.84$10.46
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$3.1B$3.0B$3.2B$3.2B$3.3B$3.3B$3.3B$3.5B$3.6B$3.5B$3.5B$3.7B
Operating Expenses$2.8B$3.2B$2.9B$2.9B$3.0B$3.1B$3.0B$3.1B$3.2B$3.1B$3.1B$3.3B
Operating Profit$252.0M$-123.0M$321.0M$295.0M$254.0M$217.0M$326.0M$395.0M$397.0M$382.0M$387.0M$452.0M
Operating Margin8.3%-4.0%10.1%9.2%7.7%6.5%9.8%11.2%11.1%10.9%10.9%12.1%
Interest$50.0M$49.0M$47.0M$48.0M$50.0M$63.0M$56.0M$57.0M$56.0M$55.0M$55.0M$61.0M
Profit Before Tax$239.0M$-147.0M$297.0M$268.0M$211.0M$184.0M$275.0M$305.0M$337.0M$191.0M$320.0M$386.0M
Tax$23.1M$-13.4M$23.2M$23.2M$19.5M$21.9M$22.6M$21.8M$22.4M$13.5M$13.0M$22.6M
Net Profit$183.0M$-167.0M$228.0M$205.0M$169.0M$143.0M$213.0M$238.0M$261.0M$165.0M$278.0M$299.0M
EPS$2.11$-1.97$2.69$2.44$2.01$1.70$2.52$2.84$3.12$1.98$3.35$3.64

Over the 10 years reported for Labcorp Holdings Inc., borrowings increased from $5.8B in 2016 to $7.2B in 2025, cash stood at $532.0M in the latest year, shareholders' equity was $8.0M, current assets covered current liabilities 1.42 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$14.2B$16.6B$16.2B$18.0B$20.1B$20.4B$20.2B$16.7B$18.4B$18.4B
Current Assets$2.5B$2.7B$2.8B$3.0B$5.1B$5.3B$4.6B$3.8B$4.8B$4.0B
Cash$434.0M$317.0M$427.0M$338.0M$1.3B$1.5B$321.0M$537.0M$1.5B$532.0M
Inventory$205.0M$228.0M$237.0M$245.0M$423.0M$401.0M$471.0M$475.0M$493.0M$535.0M
Receivables$1.5B$1.8B$1.9B$2.0B$3.0B$3.0B$2.0B$2.1B$2.1B$2.3B
Fixed Assets$1.7B$1.7B$1.8B$2.6B$2.7B$2.8B$2.8B$2.9B$3.0B$3.1B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$58.0M$58.0M$61.0M$85.0M$74.0M$61.0M$66.0M$27.0M$16.0M$154.0M
Other Assets$6.4B$7.5B$7.4B$7.9B$7.8B$8.0B$6.1B$6.1B$6.4B$6.8B
Total Liabilities$8.7B$9.8B$9.2B$10.5B$10.6B$10.1B$10.0B$8.8B$10.3B$9.8B
Current Liabilities$1.8B$2.2B$1.9B$2.7B$3.1B$2.8B$3.1B$3.2B$3.3B$2.8B
Borrowings$5.8B$6.8B$6.1B$7.1B$6.8B$6.3B$6.2B$6.0B$7.3B$7.2B
Other Liabilities$2.9B$3.1B$3.1B$3.4B$3.9B$3.7B$3.8B$2.9B$3.0B$2.6B
Equity$12.0M$12.0M$12.0M$9.0M$9.0M$9.0M$8.0M$8.0M$8.0M$8.0M
Reserves$5.5B$6.8B$7.0B$7.6B$9.4B$10.3B$10.1B$7.9B$8.1B$8.6B

For Labcorp Holdings Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $1.2B; free cash flow was positive in 10 of 10 years; financing activities used $496.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$1.2B$1.5B$1.3B$1.4B$2.1B$3.1B$2.0B$1.3B$1.6B$1.6B
Investing Cash Flow$-1.1B$-2.6B$-173.0M$-1.7B$-1.0B$-1.3B$-2.1B$-1.6B$-1.9B$-1.6B
Financing Cash Flow$52.0M$-316.0M$-695.0M$-422.0M$-105.0M$-1.7B$-1.1B$495.0M$23.0M$-496.0M
Net Cash Flow$-283.0M$-117.0M$110.0M$-89.0M$983.0M$152.0M$-1.0B$107.0M$982.0M$-986.0M
Free Cash Flow$897.0M$1.1B$926.0M$1.0B$1.8B$2.6B$1.5B$874.0M$1.1B$1.2B

Valuation & Return Ratios

MetricValue
PEG Ratio0.76
EV / EBITDA14.84
FCF Yield4.57%
Quick Ratio1.53
Interest Coverage7.12
Return 1Y17.35%
Return 3Y72.00%
Return 5Y40.46%

Labcorp Holdings Inc. (LH) financials — frequently asked questions

What is Labcorp Holdings Inc.'s annual revenue?

Labcorp Holdings Inc. (LH) reported annual revenue of $14.0B in its most recent fiscal year.

What is Labcorp Holdings Inc.'s net profit?

Labcorp Holdings Inc. (LH) reported net profit of $877.0M in its most recent fiscal year.

What is LH EV/EBITDA?

Labcorp Holdings Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 14.84.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
LH Overview LH Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.